Skip Content
You are currently on the new version of our website. Access the old version .

Pharmaceuticals, Volume 3, Issue 4

2010 April - 24 articles

  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
  • You may sign up for email alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (24)

  • Article
  • Open Access
76 Citations
18,054 Views
7 Pages

26 April 2010

In the United States non-steroidal anti-inflammatory drugs (NSAID) are freely available over-the-counter. Because of the adverse effects on the kidneys and the popularity of these drugs, unregulated use of NSAIDs is an under recognized and potentiall...

  • Article
  • Open Access
10,271 Views
9 Pages

23 April 2010

Cdk5 is essential for neuronal differentiation processes in the brain. Activation of Cdk5 requires the association with the mostly neuron-specific p35 or p39. Overactivation of CDK5 by cleavage of p35 into p25 is thought to be involved in neurodegene...

  • Review
  • Open Access
29 Citations
18,283 Views
38 Pages

Thrombospondin-1 as a Paradigm for the Development of Antiangiogenic Agents Endowed with Multiple Mechanisms of Action

  • Marco Rusnati,
  • Chiara Urbinati,
  • Silvia Bonifacio,
  • Marco Presta and
  • Giulia Taraboletti

23 April 2010

Uncontrolled neovascularization occurs in several angiogenesis-dependent diseases, including cancer. Neovascularization is tightly controlled by the balance between angiogenic growth factors and antiangiogenic agents. The various natural angiogenesis...

  • Review
  • Open Access
7 Citations
10,385 Views
7 Pages

22 April 2010

Tyrosine kinase inhibitors are a new class of anticancer drugs, that are capable of directly interacting with the catalytic site of the target enzyme and thereby inhibiting catalysis. Therapeutically useful tyrosine kinase inhibitors are not specific...

  • Review
  • Open Access
27 Citations
12,943 Views
25 Pages

Safety, Tolerability, and Immunogenicity of Interferons

  • Michael G. Tovey and
  • Christophe Lallemand

20 April 2010

Interferons (IFNs) are class II cytokines that are key components of the innate immune response to virus infection. Three IFN sub-families, type I, II, and III IFNs have been identified in man, Recombinant analogues of type I IFNs, in particular IFNα...

  • Review
  • Open Access
18 Citations
15,275 Views
15 Pages

20 April 2010

Capsule endoscopy and balloon endoscopy, advanced modalities that allow full investigation of the entire small intestine, have revealed that nonsteroidal anti-inflammatory drugs (NSAIDs) can cause a variety of abnormalities in the small intestine. Re...

  • Review
  • Open Access
49 Citations
14,406 Views
23 Pages

20 April 2010

The expression and activity of different channel types mark and regulate specific stages of cancer establishment and progression. Blocking channel activity impairs the growth of some tumors, both in vitro and in vivo, which opens a new field for phar...

  • Review
  • Open Access
149 Citations
27,661 Views
23 Pages

Lysostaphin: A Staphylococcal Bacteriolysin with Potential Clinical Applications

  • Maria do Carmo de Freire Bastos,
  • Bruna Gonçalves Coutinho and
  • Marcus Lívio Varella Coelho

19 April 2010

Lysostaphin is an antimicrobial agent belonging to a major class of antimicrobial peptides and proteins known as the bacteriocins. Bacteriocins are bacterial antimicrobial peptides which generally exhibit bactericidal activity against other bacteria....

  • Review
  • Open Access
23 Citations
14,128 Views
17 Pages

The Impact of CYP2D6 Genotyping on Tamoxifen Treatment

  • Roberta Ferraldeschi and
  • William G. Newman

15 April 2010

Tamoxifen remains a cornerstone of treatment for patients with oestrogen-receptor-positive breast cancer. Tamoxifen efficacy depends on the biotransformation, predominantly via the cytochrome P450 2D6 (CYP2D6) isoform, to the active metabolite endoxi...

  • Article
  • Open Access
2 Citations
9,404 Views
14 Pages

14 April 2010

We have proposed a unifying hypothesis of the etiopathogenesis of autoimmunity that defines autoimmunity as a type I interferon (IFN) immunodeficiency syndrome. We have examined toxicity and potential efficacy in two phase I (type 1 diabetes [T1D], m...

  • Article
  • Open Access
49 Citations
13,716 Views
15 Pages

Imperatoxin A, a Cell-Penetrating Peptide from Scorpion Venom, as a Probe of Ca2+-Release Channels/Ryanodine Receptors

  • Georgina B. Gurrola,
  • E. Michelle Capes,
  • Fernando Z. Zamudio,
  • Lourival D. Possani and
  • Héctor H. Valdivia

13 April 2010

Scorpion venoms are rich in ion channel-modifying peptides, which have proven to be invaluable probes of ion channel structure-function relationship. We previously isolated imperatoxin A (IpTxa), a 3.7 kDa peptide activator of Ca2+-release channels/r...

  • Review
  • Open Access
80 Citations
18,425 Views
9 Pages

12 April 2010

Inflammatory Bowel Diseases (IBD) are an immune mediated chronic or relapsing disorders of the gastrointestinal (GI) tract. IBD is characterized by a chronic intestinal inflammatory process with various components contributing to the pathogenesis of...

  • Article
  • Open Access
4 Citations
10,730 Views
14 Pages

1 April 2010

This research report assessed the differences in resistance rates and antimicrobial usage-versus-susceptibility relationships of Pseudomonas aeruginosa found in various hospital patient care areas. A simplified case control study was also performed t...

  • Article
  • Open Access
8 Citations
10,864 Views
7 Pages

Synthesis and Neuroprotective Action of Optically Pure Neoechinulin A and Its Analogs

  • Toshiaki Aoki,
  • Kensuke Ohnishi,
  • Masaaki Kimoto,
  • Satoshi Fujieda,
  • Kouji Kuramochi,
  • Toshifumi Takeuchi,
  • Atsuo Nakazaki,
  • Nobuo Watanabe,
  • Fumio Sugawara and
  • Susumu Kobayashi
  • + 1 author

31 March 2010

We developed an efficient, stereoselective synthetic method for the diketopiperazine moiety of neoechinulin A and its derivatives. The intramolecular cyclization at 80 ºC proceeded with minimal racemization of the stereogenic center at C-12 on neoech...

  • Review
  • Open Access
267 Citations
29,567 Views
33 Pages

Cell-Penetrating Peptides—Mechanisms of Cellular Uptake and Generation of Delivery Systems

  • Sara Trabulo,
  • Ana Luísa Cardoso,
  • Miguel Mano and
  • Maria C. Pedroso De Lima

30 March 2010

The successful clinical application of nucleic acid-based therapeutic strategies has been limited by the poor delivery efficiency achieved by existing vectors. The development of alternative delivery systems for improved biological activity is, there...

  • Review
  • Open Access
126 Citations
27,759 Views
22 Pages

Antiproliferative Properties of Type I and Type II Interferon

  • Joseph Bekisz,
  • Samuel Baron,
  • Corey Balinsky,
  • Angel Morrow and
  • Kathryn C. Zoon

30 March 2010

The clinical possibilities of interferon (IFN) became apparent with early studies demonstrating that it was capable of inhibiting tumor cells in culture and in vivo using animal models. IFN gained the distinction of being the first recombinant cytoki...

  • Review
  • Open Access
67 Citations
42,317 Views
29 Pages

Beta-Adrenergic Agonists

  • Giovanni Barisione,
  • Michele Baroffio,
  • Emanuele Crimi and
  • Vito Brusasco

30 March 2010

Inhaled β2-adrenoceptor (β2-AR) agonists are considered essential bronchodilator drugs in the treatment of bronchial asthma, both as symptoms-relievers and, in combination with inhaled corticosteroids, as disease-controllers. In this article, we firs...

  • Article
  • Open Access
30 Citations
12,966 Views
18 Pages

Cell-Penetrating Peptides: A Comparative Study on Lipid Affinity and Cargo Delivery Properties

  • Paolo Ruzza,
  • Barbara Biondi,
  • Anna Marchiani,
  • Nicola Antolini and
  • Andrea Calderan

30 March 2010

A growing number of natural and/or synthetic peptides with cell membrane penetrating capability have been identified and described in the past years. These molecules have been considered promising tools for delivering bioactive compounds into various...

  • Review
  • Open Access
24 Citations
12,915 Views
21 Pages

29 March 2010

Hypertension is still one of the major causes of death from cardiovascular failure. Increased salt intake may aggravate the rise in blood pressure and the development of consequential damage of the heart, the vessels and other organs. The general nec...

  • Review
  • Open Access
6 Citations
12,199 Views
24 Pages

26 March 2010

Rat experimental models are used extensively for studying physiological mechanisms and treatments of hypertension and diabetes co-existence. Each one of these conditions is a major risk factor for cardiovascular disease (CVD), and the combination of...

  • Review
  • Open Access
22 Citations
16,682 Views
15 Pages

Lambda Interferons: New Cytokines with Old Functions

  • Ole J. Hamming,
  • Hans Henrik Gad,
  • Søren Paludan and
  • Rune Hartmann

25 March 2010

Interferon lambda (IFN-λ) is a member of the class II cytokine family, and like the other members of this family, they are small helical proteins. Since their discovery significant efforts have been made to determine their role in innate and adaptive...

  • Review
  • Open Access
55 Citations
13,223 Views
29 Pages

25 March 2010

Chagas’ disease, or American trypanosomosiasis, has been the most relevant illness produced by protozoa in Latin America. Synthetic medicinal chemistry efforts have provided an extensive number of chemodiverse hits at the “active-to-hit” stage. Howev...

  • Review
  • Open Access
169 Citations
24,479 Views
77 Pages

25 March 2010

Alzheimer’s disease (AD), Parkinson’s disease (PD) and amyotrophic lateral sclerosis (ALS) are the most common human adult-onset neurodegenerative diseases. They are characterized by prominent age-related neurodegeneration in selectively vulnerable n...

  • Article
  • Open Access
6 Citations
12,394 Views
13 Pages

24 March 2010

Increasing evidence for the role of pharmacogenetics in treatment resistance to the antiplatelet agent clopidogrel has been gained during the last years. Apart from CYP2C19 genetic polymorphisms, nongenetic factors, particularly drug-drug interaction...

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Pharmaceuticals - ISSN 1424-8247